Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Page 1
Occurrence of focal myositis during Behçet's disease: The identification of a specific vasculitis-associated focal myopathy.
Gallay L, Hot A, Allenbach Y, Maucort-Boulch D, Comarmond C, Marques C, Perard L, Simon A, Mariampillai K, Cacoub P, Mery-Bossard L, Cathebras P, Feasson L, Berezne A, Morati C, Lessard L, Faruch M, Streichenberger N, Saadoun D; From the French Behçet's Network. Gallay L, et al. Among authors: comarmond c. Neuropathol Appl Neurobiol. 2023 Apr;49(2):e12900. doi: 10.1111/nan.12900. Neuropathol Appl Neurobiol. 2023. PMID: 36919233
CONCLUSIONS: FM occurring during BD appears to be part of the systemic vasculitis process and presents as a vasculitis-associated focal myopathy with a specific clinico-histological pattern. Patients with this association require long-term follow-up and adapted management. …
CONCLUSIONS: FM occurring during BD appears to be part of the systemic vasculitis process and presents as a vasculitis-associated focal myop …
Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial.
CORIMUNO-19 Collaborative group. CORIMUNO-19 Collaborative group. Lancet Rheumatol. 2022 Jan;4(1):e24-e32. doi: 10.1016/S2665-9913(21)00315-5. Epub 2021 Nov 17. Lancet Rheumatol. 2022. PMID: 34812424 Free PMC article.
Further studies are warranted to evaluate the effect of sarilumab on long-term survival. FUNDING: Assistance publique-Hopitaux de Paris....
Further studies are warranted to evaluate the effect of sarilumab on long-term survival. FUNDING: Assistance publique-Hopitaux de Par …
Spectrum and Outcome of Noninfectious Aortitis.
Ferfar Y, Morinet S, Espitia O, Agard C, Vautier M, Comarmond C, Desbois AC, Domont F, Resche-Rigon M, Cacoub P, Biard L, Saadoun D; French Study Group for Large Vessel Vasculitis (GEFA). Ferfar Y, et al. Among authors: comarmond c. J Rheumatol. 2021 Oct;48(10):1583-1588. doi: 10.3899/jrheum.201274. Epub 2021 Jul 1. J Rheumatol. 2021. PMID: 34210830
OBJECTIVE: To assess the spectrum and long-term outcome of patients with noninfectious aortitis. METHODS: We performed a retrospective multicenter study of 353 patients (median age at diagnosis was 62 [IQR 46-71] yrs and 242 [68.6%] patients were women) with noninfectious …
OBJECTIVE: To assess the spectrum and long-term outcome of patients with noninfectious aortitis. METHODS: We performed a retrospectiv …
D-Dimer Level and Neutrophils Count as Predictive and Prognostic Factors of Pulmonary Embolism in Severe Non-ICU COVID-19 Patients.
Thoreau B, Galland J, Delrue M, Neuwirth M, Stepanian A, Chauvin A, Dellal A, Nallet O, Roriz M, Devaux M, London J, Martin-Lecamp G, Froissart A, Arab N, Ferron B, Groff MH, Queyrel V, Lorut C, Regard L, Berthoux E, Bayer G, Comarmond C, Lioger B, Mekinian A, Szwebel TA, Sené T, Amador-Borrero B, Mangin O, Sellier PO, Siguret V, Mouly S, Kevorkian JP, Lariboisière Covid Group, Vodovar D, Sene D. Thoreau B, et al. Among authors: comarmond c. Viruses. 2021 Apr 26;13(5):758. doi: 10.3390/v13050758. Viruses. 2021. PMID: 33926038 Free PMC article.
PE occurrence was independently associated with the lack of long-term anticoagulation or thromboprophylaxis (OR [95%CI], 72.3 [3.6-4384.8]) D-dimers 2000 ng/mL (26.3 [4.1-537.8]) and neutrophils 7.0 G/L (5.8 [1.4-29.5]). ...
PE occurrence was independently associated with the lack of long-term anticoagulation or thromboprophylaxis (OR [95%CI], 72.3 [3.6-43 …
Apremilast in Refractory Behçet's Syndrome: A Multicenter Observational Study.
Vieira M, Buffier S, Vautier M, Le Joncour A, Jamilloux Y, Gerfaud-Valentin M, Bouillet L, Lazaro E, Barete S, Misery L, Gobert D, Goulenok T, Fain O, Sacre K, Sève P, Cacoub P, Comarmond C, Saadoun D. Vieira M, et al. Among authors: comarmond c. Front Immunol. 2021 Feb 4;11:626792. doi: 10.3389/fimmu.2020.626792. eCollection 2020. Front Immunol. 2021. PMID: 33613571 Free PMC article.
There remains a need for safe and effective treatment for joint lesions in BS. We report the long-term safety and effectiveness of apremilast in refractory joint and mucocutaneous manifestations of BS. ...
There remains a need for safe and effective treatment for joint lesions in BS. We report the long-term safety and effectiveness of ap …
Long-Term Outcome and Prognosis Factors of Isolated Aortitis.
Ferfar Y, Morinet S, Espitia O, Agard C, Vautier M, Comarmond C, Desbois AC, Domont F, Fouret PJ, Redheuil A, Cluzel P, Chiche L, Koskas F, Resche-Rigon M, Cacoub P, Biard L, Saadoun D; French Study Group for Large Vessel Vasculitis (GEFA). Ferfar Y, et al. Among authors: comarmond c. Circulation. 2020 Jul 7;142(1):92-94. doi: 10.1161/CIRCULATIONAHA.120.045957. Epub 2020 Jul 6. Circulation. 2020. PMID: 32628555 No abstract available.
Prognosis of large vessel involvement in large vessel vasculitis.
Vautier M, Dupont A, de Boysson H, Comarmond C, Mirault T, Mekinian A, Lambert M, Ferfar Y, Aouba A, Cacoub P, Resche-Rigon M, Saadoun D. Vautier M, et al. Among authors: comarmond c. J Autoimmun. 2020 Mar;108:102419. doi: 10.1016/j.jaut.2020.102419. Epub 2020 Feb 5. J Autoimmun. 2020. PMID: 32035747
CONCLUSION: This large nationwide cohort of LVI provided prognosis factors of vascular complications in LVV patients. TAK and GCA-LVI have different long-term outcome in term of aneurysm development, relapse and revascularization....
CONCLUSION: This large nationwide cohort of LVI provided prognosis factors of vascular complications in LVV patients. TAK and GCA-LVI have d …
Long-Term Outcome of Ustekinumab Therapy for Behcet's Disease.
Mirouse A, Barete S, Desbois AC, Comarmond C, Sène D, Domont F, Bodaghi B, Ferfar Y, Cacoub P, Saadoun D; French Behçet's Network. Mirouse A, et al. Among authors: comarmond c. Arthritis Rheumatol. 2019 Oct;71(10):1727-1732. doi: 10.1002/art.40912. Epub 2019 Aug 12. Arthritis Rheumatol. 2019. PMID: 31008548
OBJECTIVE: Oral ulcers, the hallmark lesion of Behcet's disease (BD), can be disabling and resistant to conventional treatment, and there is a need for safe and effective treatment. We undertook this study to investigate the long-term safety and efficacy of ustekinumab the …
OBJECTIVE: Oral ulcers, the hallmark lesion of Behcet's disease (BD), can be disabling and resistant to conventional treatment, and there is …
Considering hepatitis C virus infection as a systemic disease.
Cacoub P, Comarmond C. Cacoub P, et al. Among authors: comarmond c. Semin Dial. 2019 Mar;32(2):99-107. doi: 10.1111/sdi.12758. Epub 2018 Dec 13. Semin Dial. 2019. PMID: 30549107 Free article. Review.
These end-organ effects of HCV may dominate the clinical course beyond the hepatic complications and significantly worsen the long-term prognosis of infected patients. Until several years ago, the standard of care for the treatment of HCV infection had been interferon-alph …
These end-organ effects of HCV may dominate the clinical course beyond the hepatic complications and significantly worsen the long-term …
Overall survival and mortality risk factors in Takayasu's arteritis: A multicenter study of 318 patients.
Mirouse A, Biard L, Comarmond C, Lambert M, Mekinian A, Ferfar Y, Kahn JE, Benhamou Y, Chiche L, Koskas F, Cluzel P, Hachulla E, Messas E, Cacoub P, Mirault T, Resche-Rigon M, Saadoun D; French Takayasu network. Mirouse A, et al. Among authors: comarmond c. J Autoimmun. 2019 Jan;96:35-39. doi: 10.1016/j.jaut.2018.08.001. Epub 2018 Aug 17. J Autoimmun. 2019. PMID: 30122419
OBJECTIVE: To report the long term mortality in Takayasu arteritis (TA) and to identify prognosis factors. ...
OBJECTIVE: To report the long term mortality in Takayasu arteritis (TA) and to identify prognosis factors. ...
17 results